Annual meeting 2023
This year, we were honoured to be joined by Professor Oana Ciofu as a Keynote Speaker to kick off the meeting with an insightful talk on the efforts to combat biofilm infections.
The meeting was followed by the traditional ISAP Young Investigator session, chaired by Dr. Vincent Aranzana-Climent (France), Dr. Iris Minichmayr (Austria) and Dr. Sue C. Nang (Australia). It was fascinating to hear about excellent research conducted by our talented ISAP Young Investigators.
|
Presenter |
Title |
|
Noémie Prébonnaud Université de Poitiers, France |
Predicting antibacterial efficacy of linezolid on Staphylococcus aureus in cerebral infections using in vitro hollow fiber model and pharmacokinetic-pharmacodynamic modeling |
|
Aneeq Farooq University of Hamburg, Germany |
Pharmacokinetic/pharmacodynamic studies of meropenem combined with fosfomycin in a clinical K. pneumoniae isolate expressing KPC-2 carbapenemase and fosfomycin resistance |
|
Mathilde Lacroix Université de Poitiers, France |
Transcriptomic data to support in vitro semi-mechanistic PK/PD modelling of polymyxin B against Acinetobacter baumannii |
|
Chenyan Zhao Uppsalla University, Sweden |
Characterizing bacterial growth and killing kinetics of RG6006 using in vitro and in vivo time-kill studies and mechanism-based pharmacokinetic-pharmacodynamic (PKPD) modeling |
|
Thomas D. Nguyen University at Buffalo, USA |
Developing a mechanistically informed population pharmacokinetic model of vancomycin in patients undergoing intermittent hemodialysis |
|
Augustine Koh Melbourne University, Australia |
Investigating Leu10Teixobactin combinations with glycopeptides against multidrug-resistant Gram-positive pathogens |
|
Eva Wehrhahn Uppsalla University, Sweden |
Quantification of antibiotic-induced changes in bacterial counts and morphology using timelapse microscopy, image analysis, machine learning and pharmacokinetic-pharmacodynamic modelling |
|
Malin Andersson Freie Universität Berlin, Germany |
Beyond the standard ratio: Quantitative exploration of the effect of piperacillin with varying tazobactam concentrations |
|
Gert-Jan Wijnant Université catholique de Louvain, Belgium |
Population pharmacokinetics and dosing simulation of the β-lactam temocillin in liver-transplanted pediatric patients |
|
Hélène Thirot Université catholique de Louvain, Belgium |
Linezolid toxicity in clinical practice: Towards a better detection of at-risk patients? Interim analysis of a prospective multicentric study |
|
Maria Sanz-Codina Medical University of Vienna, Austria |
Plasma and soft tissue pharmacokinetics of cefiderocol in healthy volunteers |
Many congratulations to the winners of the Young Investigator session:
Oral presentation: Mr. Aneeq Farooq (University of Hamburg, Germany)
Rapid fire talk: Dr. Gert-Jan Wijnant (UCLouvain, Belgium)
We were delighted to see many of you in Copenhagen and we look forward to seeing you again in Barcelona next year!
